US FDA Safety Communication on Breast Implant Associated Squamous Cell Carcinoma BIA-SCC)
Aesthetic Plast Surg
.
2023 Apr;47(2):892-893.
doi: 10.1007/s00266-023-03283-5.
Authors
Mark L Jewell
1
2
3
,
Jennifer L Walden
3
4
5
6
,
Montserrat Fontbona
3
7
8
9
,
Lina Triana
10
Affiliations
1
Plastic Surgery, Oregon Health Science University, Portland, Oregon, USA.
2
Private Practice, Eugene, Oregon, USA.
3
Patient Safety Committee, International Society of Aesthetic Plastic Surgery (ISAPS), Mount Royal, NJ, USA.
4
The Aesthetic Society (American Society for Aesthetic Plastic Surgery), Garden Grove, USA.
5
University of Texas Southwestern, Dallas, Texas, USA.
6
Private Practice, Austin, Texas, USA.
7
Hospital Militar de Santiago, Santiago, Chile.
8
Private Practice Clínica Aurea, Santiago, Chile.
9
Universidad de Los Andes, Bogotá, Colombia.
10
International Society of Aesthetic Plastic Surgery (ISAPS), Mount Royal, NJ, USA.
PMID:
36823252
DOI:
10.1007/s00266-023-03283-5
No abstract available
Publication types
News
MeSH terms
Breast Implantation* / adverse effects
Breast Implants* / adverse effects
Breast Neoplasms* / surgery
Carcinoma, Squamous Cell*
Female
Humans
Lymphoma, Large-Cell, Anaplastic* / pathology